AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bio Essence Corporation

$0.18 +$0.12 (+203.33%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.18
Day Range
$0.18$0.18
Year Range
$0.05$0.52
Market Cap
7.21M
AVG Volume
860
Trailing/Forward PE
4.88/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2794.71K
26 Q1500.54K
25 Q41.48M
25 Q3136.8K
25 Q2259.12K
25 Q122.19K
24 Q4147.56K
24 Q3134.69K
24 Q241.7K
24 Q10
Net Income (USD)
-2M-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2270.08K
26 Q1205.37K
25 Q41.03M
25 Q313K
25 Q259.86K
25 Q1-205.75K
24 Q4-27.56K
24 Q3-1.2M
24 Q2-215.68K
24 Q1-154K
Operating Income (USD)
-500K0500K1M1.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2279.29K
26 Q1215.79K
25 Q41.03M
25 Q314.25K
25 Q261.22K
25 Q1-205.09K
24 Q43.85K
24 Q3-146.45K
24 Q2-165.01K
24 Q1-62.02K
EBITDA (USD)
-2M-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2382.95K
26 Q1215.79K
25 Q41.03M
25 Q313.61K
25 Q261.27K
25 Q1-205.09K
24 Q4-26.73K
24 Q3-1.2M
24 Q2-214.04K
24 Q1-121.95K
Cash Flows (USD)
-500K0500K1M1.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q259.65K
26 Q1-411.97K
25 Q41.24M
25 Q3186.97K
25 Q2167.8K
25 Q1-26.07K
24 Q4423.07K
24 Q3357.14K
24 Q215.27K
24 Q1-171.61K
EPS (USD)
-0.04-0.0200.020.0424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.01
26 Q10
25 Q40.03
25 Q30
25 Q20
25 Q1-0.01
24 Q4-0
24 Q3-0.03
24 Q2-0.01
24 Q1-0
Expenses (USD)
-100K0100K200K300KSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2190.97K
26 Q1103.56K
25 Q4113.79K
25 Q381.51K
25 Q2107.42K
25 Q1225.68K
24 Q4103.04K
24 Q3227.44K
24 Q2194.2K
24 Q1151.83K
Cash & Debt (USD)
01M2M3MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2675
26 Q136.18K
25 Q40
25 Q328.74K
25 Q20
25 Q10
24 Q41.37K
24 Q329.82K
24 Q29.49K
24 Q123
Debt ratios
-20-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Debt ratios by quarter
PeriodDebt ratios
26 Q20.95
26 Q11.16
25 Q41.74
25 Q3-15.37
25 Q2-1.89
25 Q1-1.67
24 Q4-1.73
24 Q3-1.78
24 Q2-4.65
24 Q1-2.57
Margins
0%25%50%75%100%23 Q424 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Margins by quarter
PeriodMargins
26 Q259.17%
26 Q163.8%
25 Q477.29%
25 Q370%
25 Q265.08%
25 Q192.78%
24 Q472.45%
24 Q360.13%
24 Q270%
23 Q49.26%
Return on Capital
-50%-25%0%25%50%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Return on Capital by quarter
PeriodReturn on Capital
26 Q211.53%
26 Q1-14.39%
25 Q4-49.64%
25 Q3-0.42%
25 Q2-1.92%
25 Q16.48%
24 Q40.93%
24 Q340.78%
24 Q212.38%
24 Q110.72%
Shares Outstanding
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Shares Outstanding by quarter
PeriodShares Outstanding
26 Q250.89M
26 Q144.95M
25 Q438.01M
25 Q338.01M
25 Q238.01M
25 Q138.01M
24 Q438.01M
24 Q338.01M
24 Q238.01M
24 Q138.01M
Book Value Per Share (USD)
-0.1-0.0500.0524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.05
26 Q1-0.03
25 Q4-0.05
25 Q3-0.08
25 Q2-0.08
25 Q1-0.08
24 Q4-0.08
24 Q3-0.08
24 Q2-0.05
24 Q1-0.04
Total Assets (USD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q24M
26 Q1789.03K
25 Q4422.47K
25 Q3184.53K
25 Q2112.69K
25 Q1365.72K
24 Q4281.02K
24 Q3715.97K
24 Q22.1M
24 Q1703.91K
Employee Count
051015202020212022202320242025
BIOE Employee Count by quarter
PeriodEmployee Count
20254
20242
202312
202211
202115
202011
PE Ratio
510152025med 9.28Apr 26May 26May 26Jun 26Jul 26Aug 26Sep 26
BIOE PE Ratio by quarter
PeriodPE Ratio
Sep 266.1
Sep 266.1
Sep 266.37
Aug 266.37
Aug 268.38
Aug 268.38
Aug 268.6
Jul 269.28
Jul 269.28
Jul 269.28
Jul 269.28
Jul 269.28
Jun 269.28
Jun 266.25
Jun 268.7
Jun 268.68
May 269.42
May 269.42
May 2613.07
May 2621.21
May 2621.21
Apr 2619.09
Apr 2616.96
Apr 2616.96
Apr 267.83
Mar 267.21
Free Cash Flow Yield
-20%0%20%40%60%med 10.42%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2611.62%
Sep 2611.62%
Sep 2611.13%
Aug 2611.13%
Aug 268.46%
Aug 268.46%
Aug 2610.53%
Jul 269.75%
Jul 269.75%
Jul 269.75%
Jul 269.75%
Jul 269.75%
Jun 269.75%
Jun 2614.48%
Jun 2610.41%
Jun 2610.43%
May 269.61%
May 269.61%
May 266.93%
May 268.26%
May 268.26%
Apr 269.18%
Apr 2610.32%
Apr 2610.32%
Apr 2622.37%
Mar 2624.29%
Mar 2613.19%
Mar 2635.96%
Mar 2635.96%
Feb 2621.98%
Feb 2638.78%
Feb 2635.96%
Feb 2635.96%
Jan 2638.78%
Jan 2638.78%
Jan 2638.78%
Jan 2634.1%
Jan 2632.96%
Dec 2535.96%
Dec 2532.42%
Dec 2538.04%
Dec 2538.04%
Nov 2538.04%
Nov 2538.04%
Nov 2534.1%
Nov 2541.82%
Oct 2534.16%
Oct 2535.15%
Oct 2535.31%
Oct 2528.2%
Oct 2526.65%
Sep 2526.36%
Sep 2526.36%
Sep 2525.8%
Sep 2526.65%
Aug 2520.21%
Aug 2520.21%
Aug 2525.53%
Aug 2521.31%
Aug 2517.99%
Jul 2518.4%
Jul 2514.75%
Jul 2521.31%
Jul 2521.31%
Jun 2518.4%
Jun 2518.4%
Jun 2511.91%
Jun 258.8%
May 258.8%
May 259.55%
May 259.55%
May 257.74%
May 257.14%
Apr 257.97%
Apr 257.97%
Apr 257.67%
Apr 256.57%
Mar 256.59%
Mar 25-0.04%
Mar 25-0.04%
Mar 25-0.04%
Feb 25-0.03%
Feb 25-0.03%
Feb 25-0.03%
Feb 25-0.03%
Jan 25-0.03%
Jan 25-0.03%
Jan 25-0.03%
Jan 25-0.04%
Jan 25-0.04%
Dec 24-0.03%
Dec 24-0.03%
Dec 24-0.03%
Dec 24-0.03%
Nov 24-0.04%
Nov 24-0.03%
Nov 24-0.03%
Nov 24-6.78%
Nov 24-4.91%
Oct 24-3.36%
Price to Sales
-2000-100001000med 4.69Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOE Price to Sales by quarter
PeriodPrice to Sales
Sep 263.18
Sep 263.18
Sep 263.32
Aug 263.32
Aug 264.37
Aug 264.37
Aug 264.73
Jul 265.11
Jul 265.11
Jul 265.11
Jul 265.11
Jul 265.11
Jun 265.11
Jun 263.44
Jun 264.79
Jun 264.78
May 265.18
May 265.18
May 267.19
May 2610.02
May 2610.02
Apr 269.01
Apr 268.01
Apr 268.01
Apr 263.7
Mar 263.41
Mar 2610.08
Mar 263.7
Mar 263.7
Feb 266.05
Feb 263.43
Feb 263.7
Feb 263.7
Jan 263.43
Jan 263.43
Jan 263.43
Jan 263.9
Jan 264.03
Dec 253.7
Dec 254.1
Dec 253.49
Dec 253.49
Nov 253.49
Nov 253.49
Nov 253.9
Nov 253.91
Oct 254.79
Oct 254.65
Oct 254.63
Oct 255.8
Oct 256.14
Sep 256.2
Sep 256.2
Sep 256.34
Sep 256.14
Aug 258.09
Aug 258.09
Aug 256.41
Aug 2510.43
Aug 2512.35
Jul 2512.08
Jul 2515.07
Jul 2510.43
Jul 2510.43
Jun 2512.08
Jun 2512.08
Jun 2518.67
Jun 2525.26
May 2525.26
May 2523.28
May 2523.28
May 2524.87
May 2526.99
Apr 2524.17
Apr 2524.17
Apr 2525.11
Apr 2529.33
Mar 2529.22
Mar 25-272.75
Mar 25-267.45
Mar 25-284.67
Feb 25-337.89
Feb 25-450.17
Feb 25-450.17
Feb 25-428.66
Jan 25-397.21
Jan 25-450.17
Jan 25-336.3
Jan 25-293.94
Jan 25-284.67
Dec 24-357.49
Dec 24-425.01
Dec 24-397.08
Dec 24-331.01
Nov 24-317.77
Nov 24-344.25
Nov 24-333.54
Nov 24-1357.36
Nov 24-1875.28
Oct 24137.44
EV/EBITDA
510152025med 10.35Apr 26May 26May 26Jun 26Jul 26Aug 26Sep 26
BIOE EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 266.59
Sep 266.59
Sep 266.84
Aug 266.84
Aug 268.7
Aug 268.7
Aug 269.67
Jul 2610.35
Jul 2610.35
Jul 2610.35
Jul 2610.35
Jul 2610.35
Jun 2610.35
Jun 267.35
Jun 269.77
Jun 269.75
May 2610.48
May 2610.48
May 2614.09
May 2622.85
May 2622.85
Apr 2620.74
Apr 2618.63
Apr 2618.63
Apr 269.53
Mar 268.92
Price/Operating Cashflow
05101520med 5.5May 25Jul 25Oct 25Jan 26Apr 26Jun 26Sep 26
BIOE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 268.61
Sep 268.61
Sep 268.99
Aug 268.99
Aug 2611.83
Aug 2611.83
Aug 269.49
Jul 2610.25
Jul 2610.25
Jul 2610.25
Jul 2610.25
Jul 2610.25
Jun 2610.25
Jun 266.91
Jun 269.61
Jun 269.59
May 2610.4
May 2610.4
May 2614.43
May 2612.11
May 2612.11
Apr 2610.9
Apr 269.69
Apr 269.69
Apr 264.47
Mar 264.12
Mar 267.58
Mar 262.78
Mar 262.78
Feb 264.55
Feb 262.58
Feb 262.78
Feb 262.78
Jan 262.58
Jan 262.58
Jan 262.58
Jan 262.93
Jan 263.03
Dec 252.78
Dec 253.08
Dec 252.63
Dec 252.63
Nov 252.63
Nov 252.63
Nov 252.93
Nov 252.39
Oct 252.93
Oct 252.84
Oct 252.83
Oct 253.55
Oct 253.75
Sep 253.79
Sep 253.79
Sep 253.88
Sep 253.75
Aug 254.95
Aug 254.95
Aug 253.92
Aug 254.69
Aug 255.56
Jul 255.43
Jul 256.78
Jul 254.69
Jul 254.69
Jun 255.43
Jun 255.43
Jun 258.4
Jun 2511.36
May 2511.36
May 2510.47
May 2510.47
May 2512.92
May 2514.01
Apr 2512.55
Apr 2512.55
Apr 2513.04
Apr 2515.23
Mar 2515.17
Price to Book
3.544.555.5med 4.13Aug 26Aug 26Aug 26Sep 26Sep 26Sep 26
BIOE Price to Book by quarter
PeriodPrice to Book
Sep 263.95
Sep 263.95
Sep 264.13
Aug 264.13
Aug 265.43
Aug 265.43
Bio Essence Corporation
BIOE
Stockpicker

Video analysis: BIOE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.